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Summary. Discrete lesions in the medial or lateral subregion of the rostral 
caudate-putamen (CP) were induced by bilateral intracerebral injections of a 
low dose of quinolinic acid (30 nmol in 1 gl/per side) in rats. Quinolinic acid 
lesions in the lateral CP potently reversed haloperidol-induced atalepsy (0.5 mg/ 
kg,i.p.), while lesions in the medial CP were not effective. Spontaneous loco- 
motor activity was not altered significantly after quinolinic acid lesions of either 
the medial or lateral CP. These results show that the lateral CP seems to be 
important for the expression of neuroleptic-induced atalepsy and thus further 
corroborate the concept of a functional heterogenity of the striatum. 
Keywords: Catalepsy, spontaneous locomotor activity, quinolinic acid, halo- 
peridol, lateral caudate-putamen, medial caudate-putamen, rat. 
Introduction 
Systemic administration of dopamine (DA) D 1 or D 2 receptor-antagonists 
induce in rats catalepsy (0gren and Fuxe, 1988), i.e. a state of postural im- 
mobility (akinesia) and muscular rigidity. The available vidence suggests that 
catalepsy mainly originates from a blockade of D 1 or D 2 receptors in the 
caudate-putamen (CP) or a decreased presynaptic DA activity in this structure, 
since intrastriatal infusions of DA-antagonists (Elliott et al., 1990 a; Ossowska 
et al., 1990), 6-hydroxydopamine-lesions of the mesostriatal DA system or re- 
serpine treatment produced catalepsy (see Schmidt etal., 1992 for review). 
The striatum receives not only DAergic projections from the mesencephalon, 
but also extensive and topographically arranged afferents from the cerebral 
cortex (Webster, 1961) using most probably glutamate as transmitter (Fonnum, 
1984). These glutamatergic afferents play an important role for the expression 
of catalepsy, since lesions of the corticostriatal pathway reduced neuroleptic- 
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induced catalepsy (Scatton etal., 1982; Warenycia etal., 1987; Worms etal., 
1985). Furthermore, glutamate that derives from corticostriatal pathways and 
acts on the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors is 
a prerequisite for the cataleptogenic a tion of haloperidol, because infusion of 
the competitive NMDA-antagonist D-2-amino-5-phosphonopentanoic ac d
(AP-5) into the CP or frontal decortication reduced neuroleptic-induced ca- 
talepsy (Yoshida et al., 1991). In addition, striatal infusion of NMDA restored 
haloperidol-induced catalepsy in frontally decorticated rats in this study. 
It is likely that striatal output neurons bearing NMDA receptors mediate 
these anticataleptic effects, since striatal esions with quinolinic acid (Schmidt 
and Bischoff, 1988; Calderon etal., 1988) potently antagonized neuroleptic- 
induced catalepsy. Quinolinic acid is a selective agonist at the NMDA receptor 
and a potent neuroexcitotoxin which preferentially destroys piny neurons using 
GABA and substance P or enkephalin as transmitter while sparing striatal 
afferents and interneurons (Beal etal., 1988). 
However, little is known in which subregion of the CP this effect was brought 
about. There is considerable anatomical, biochemical and behavioural evidence 
for a functional differentiation of the striatum (see Goldman-Rakic and Sele- 
mon, 1990 for review). Various studies showed that the more rostral part of 
the striatum is the subregion most sensitive to the cataleptogenic effects of 
neuroleptics (Ellenbroek etal., 1985; Klockgether et al., 1988; Ossowska et al., 
1990). This view was further confirmed by the finding that infusion of the 
competitive NMDA-antagonist AP-5 into the rostral part, but not into the 
intermediate part of the CP abolished neuroleptic-induced catalepsy (Yoshida 
etal., 1991). On the other hand there is growing evidence that not only the 
anterio-posterior, but also the medio-lateral organization of the striatum is 
behaviourally relevant. Lesions in the medial part of the CP produced selective 
impairments in maze performance and discrimination learning (Wikmark et al., 
1973; Divac et al., 1978; Pisa and Cyr, 1990; Hauber and Schmidt, 1989) whereas 
lesions in the lateral part of the CP induced motor deficits in various tasks 
(Sabol etal., 1985; Pisa, 1988; Pisa and Schranz, 1988; Pisa and Cyr, 1990). 
The medial and lateral subregion of the CP mediate behavioural functions 
which are related to those mediated by the anatomically linked regions of the 
cortex. Thus it was proposed that there may exist different cortico-striatal 
functional loops which may mediate different aspects of behaviour (Alexander 
etal., 1986). In the rat, the medial subregion of the CP receives prominent 
glutamatergic projections from the medial prefrontal cortex. This cortico-striatal 
loop has been implicated in processing cognitive, i.e. non-motor, complex func- 
tions. In contrast, the lateral subregion of the CP and the anatomically related 
sensorimotor cortical regions have been suggested to mediate motor functions 
(see Robbins and Brown, 1990 for review). 
In the present study, we tested this hypothesis with regard to neuroleptic- 
induced catalepsy. We investigated the effects of lesions in the motor loop or 
cognitive loop on neuroleptic-induced catalepsy using quinolinic acid infusions 
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in the respective subregions of the rostral CP. It has been already shown that 
quinolinic acid lesions counteract neuroleptic-induced catalepsy (see above). 
However, in these studies high doses of quinolinic acid were used and the 
resulting massive striatal damage thus prevented to detect he striatal subregion 
which may be relevant o this effect. Therefore, a low dose of quinolinic acid 
was used in this study to produce relatively circumscribed lesions. It was expected 
that the expression of catalepsy which is a motor phenomenon depends of the 
integrity of the motor loop. Thus discrete lesions in the relevant motor subregion 
in the CP should counteract neuroleptic-induced catalepsy, while lesions in the 
cognitive loop should not alter this response. We used lesion placements in the 
medial and lateral subregion of the rostral CP which are not exactly in the same 
anterio-posterior plane. According to anatomical studies the medial prefrontal 
cortex projects primarily to the most rostral parts of the medial CP, while the 
sensorimotor cortex mainly projects to a more caudal subregion of the lateral 
CP (Berendse t al., 1992; McGeorge and Faull, 1989). Thus the placement for 
the medial esion was more rostral than for the lateral esion. 
We report here that quinolinic acid lesions in the lateral CP, but not in the 
medial CP potently reversed haloperidol-induced catalepsy, while spontaneous 
motor activity measured in an open field was not altered significantly after 
lesions in these striatal subregions. 
Materials and methods 
Animals 
Twenty-five male Sprague-Dawley rats (Interfauna, Tuttlingen, F.R.G.) weighing 220- 
250 g were used. They were housed in groups (5 per cage) and provided with 12 g standard 
laboratory chow per rat/day. Water was freely available. The animals were kept on a 12- 
h light-dark cycle (light 06.00-18.00). The temperature in the colony room was adjusted 
on 22 + 3 ~ Prior to this study, the animals were trained in a reaction time experiment 
(Hauber etal., 1991). No drugs were administered during this test. 
Surgery 
Surgery was performed under sodium pentobarbital (Serva, Heidelberg, F.R.G.) anaesthesia 
(50 mg/kg, i.p.) combined with atropine sulfate (Serva, Heidelberg, F.R.G.) pretreatment 
(0.25 mg/kg, i.p.). Rats were placed in a Trent Wells stereotaxic nstrument and quinolinic 
acid (Sigma, Deisenhofen, F.R.G.)(30 nmol in 1 gl 0.1 M phosphate buffer, pH 7.0) or vehicle 
(1 gl 0.1 M phosphate buffer, pH 7.0) was infused via a 26 gauge cannula t a constant rate 
over 10 min. The cannula was left in place for 2 rain after the infusion. Lesions in the medial 
or lateral subregion of the CP were made at the following placements according to the 
atlas of Paxinos and Watson (1986): medial: AP: + 2.0, L2.0, V5.0; lateral: AP + 0.9, 
L3.5, V5.5. 
Histology 
At the end of the behavioural testing the animals were anaesthetized with sodium pento- 
barbital (50mg/kg, i.p.) and transcardially perfused with 0.9% saline followed by a 4% 
solution of phosphate buffered formalin (pH 7.4). Brains were removed, postfixed and 
thereafter stored in 30% sucrose solution. Coronal sections of 40 gm were cut in a cryostat 
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(Reichert & Jung, F.R.G.) and stained with cresyl violet. The sections were examined by 
light microscopy for qualitative assessment of quinolinic acid-induced neuronal damage. 
The areas of neuronal loss and gliosis from different anterio-posterior planes revealed by 
cresyl violet staining were mapped on standardized brain sections from the atlas of Paxinos 
and Watson (1986). 
Procedure 
Two weeks after the lesion spontaneous locomotor activity of the animals was assessed in
an open field (69 x 69 cm) divided by lines in 9 squares of equal size. The open field box 
was opaque and illuminated by 4 red light bulbs (20 W); back ground noise was masked 
by a fan. Each animal was placed individually for 10 rain into the open field. Locomotor 
activity was monitored by video recording and evaluated by counting the number of line 
crossings during the observation period. The following day, the animals were tested for 
catalepsy induced by intraperitoneal injection of 0.5 mg/kg haloperidol (Janssen, Neuss, 
F.R.G.). Thirty and 60 rain after injection of haloperidol the degree of catalepsy was assessed 
in 3 tests performed in the following order (Scheel-Kriiger, 1983): 1.) Bar: both forelegs 
were placed on a horizontal bar (9 cm above the surface). 2.) Podium: one forleg was placed 
on a podium (3 cm high). 3.) Grid: an animal was clinged to a vertical wire grid. The 
latency from paw placement until complete removal of one paw from a support was 
measured (maximum 180 s) and termed here as descent latency. 
Statistics 
The data are presented as mean descent latencies and standard errors of the mean (SEM) 
for each test and group with infusions in either the medial CP (quinolonic acid, n-- 7; 
vehicle, n = 5) or lateral CP (quinolinic acid, n = 7; vehicle, n = 6). The data were subjected 
to a two-tailed Mann-Whitney U-test. Differences were considered to be significant if the 
p-value was less than 0.05. 
Results 
Spontaneous locomotor activity 
The spontaneous locomotor activity of animals with quinolinic acid lesions of  
the medial CP was not significantly different from their controls (U = 15, 
p > 0.05). No significant differences were also found between animals with 
quinolinic acid lesions in the lateral CP and their controls (U = 12, p > 0.05), 
but the locomotor activity of  laterally lesioned rats was enhanced (Fig. 1). 
Catalepsy 
Quinolinate lesions of the medial CP induced a marginal reduction of  the degree 
of catalepsy, since descent latencies were shorter than those of control animals 
in each test (Fig. 2). These differences were not significant [grid: U (30 min) 
= 8.5, p > 0.05, U (60ra in )= 12, p >0.05;  podium: U (30min)= 9, U 
(60min) = 14, p > 0.05; bar: U (30rain) = 12.5, p > 0.05, U (60min) = 17, 
p > 0.05]. 
By contrast, lesions of the lateral CP induced a significant reduction of  the 
descent latencies in each test [-grid: U (30 min) = 1, p ~< 0.002, U (60 min) = 2, 
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Fig. 1. Spontaneous locomotor activity in an open field of animals with quinolinic acid 
lesions (n = 7) or vehicle infusions (n = 5) in the medial caudate-putamen (CP) and quin- 
olinic acid lesions (n = 7) or vehicle infusions (n = 6) in the lateral caudate-putamen. Mean 
line crossings (+ SEM) were not significantly different (p > 0.05; Mann-Whitney U-test, 
two-tailed) 
p ~< 0.004; podium: U (30 rain) = 5, p ~< 0.022, U (60 min) = 6, p ~< 0.034; bar: 
U (30 min) = 6, p ~< 0.034, U (60 rain) = 0.002-] (Fig. 3). 
Histology 
Figure 4 shows the extent of the quinolinic acid-induced neuronal cell loss and 
gliosis in medial or lateral striatal areas. Quinolinic acid infusion produced a 
circumscribed area of neuronal cell loss (Fig. 5). Within this area a moderate 
degree of gliosis was found. Ventricular alterations or striatal shrinkage were 
not observed. The size of the lesions was relatively homogeneous within each 
group of lesioned animals. In addition, the overlap between the extent of lesions 
in the medial and lateral CP was minimal. In control animals no signs of 
neurodegeneration were detected except gliosis along the cannula tack and at 
the cannula tip (not shown). 
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Fig. 2. Descent latencies (+ SEM) of animals with quinolinic acid lesions (n = 7) or vehicle 
infusions (n-- 5) in the medial caudate-putamen (CP) tested for haloperidol (0.5mg/kg, 
i.p.)-induced catalepsy. Descent latencies were not significantly different (p > 0.05; Mann- 
Whitney U-test, two-tailed) 
Discussion 
The histological examination of the striatal tissue revealed that a low dose of 
quinolinic acid, a potent neuroexcitotoxin and a selective agonist at the NMDA 
subtype of glutamate receptors, produced consistenly a circumscribed neuronal 
loss and a reactive gliosis without ventricular alterations. This result confirms 
previous findings showing that even low doses of quinolinate produced a prom- 
inent neuronal degeneration (Churchill et al., 1990; Davies and Roberts, 1988) 
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Fig. 3. Descent latencies ( + SEM) of animals with quinolinic acid lesions (n = 7) or vehicle 
infusions (n = 6) in the lateral caudate-putamen (CP) tested for haloperidol (0.5 mg/kg,i.p.)- 
induced catalepsy. * p < 0.05; ** p < 0.005; Mann-Whitney U-test, two-tailed 
and that the threshold ose of quinolinate producing striatal esions of a con- 
sistent size is about 30nmol (Davies and Roberts, 1988). Numerous studies 
have shown that striatal quinolinic acid injections induced a pronounced e- 
generation of spiny neurons containing GABA and substance P/enkephalin, 
whilst aspiny neurons were preserved (see Beal, 1992 for review). In addition, 
cholinergic neurons were spared at least at the dose used here (Davies and 
Roberts, 1988). Thus quinolinic acid-induced behavioural effects observed in 
the present study are most probably due to the loss of striatal GABAergic 
projection eurons bearing NMDA receptors. 
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Fig. 4. Coronal sections howing the location and extent of the lateral (right) and medial 
(left) quinolinic acid lesions of the caudate-putamen, defined by areas of neuronal loss 
(n = 7, respectively). Numbers represent the anterio-posterior plane; scaling of the abscissae 
in mm (based on the atlas of Paxinos and Watson, 1986) 
The present study revealed that relatively small lesions of either the medial 
or lateral CP did not significantly affect spontaneous locomotor activity. This 
is accordance with a report of Sanberg et al. (1989) demonstrating that extensive 
lesions with quinolinic acid doses of 150-225 nmol are required to produce 
locomotor abnormalities (but see Emerich et al., 1991). 
Furthermore, we found that lateral striatal esions induced a massive anti- 
cataleptic effect while medial esions were not effective. At variance with these 
results are data from Calderon etal. (1988) showing that only striatal infusion 
of high doses (150-225 nmol) quinolinate dose-dependently abolished haloper- 
idol-induced catalepsy while a lower dose (75 nmol) induced no overall signif- 
icant decrease in the catalepsy response. Several reasons may contribute to these 
discrepancies: First, in the study of Calderon etal. (1988) a different lesion 
placement (coordinates with reference to bregma: AP + 1.3 mm; ML+ 2.5 mm, 
DV 5.2 mm from dura) and twice the dose of haloperidol was used, thus more 
extensive lesions were probably necessary to reduce the catalepic response. 
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Fig. 5. Photomicrograph showing the borderline of intact and damaged striatal tissue after 
quinolinic acid lesion (30 nmol) in the rat striatum. In intact tissue (left) numerous cresyl 
stained neurons can be seen which are absent in lesioned tissue (right). Magnification 128 x 
Second, intrastriatal quinolinic acid injection in doses of about 200 nmol induced 
ventricular enlargement, s riatal atrophy (e.g. Emerich et al., 1991) and cerebral 
oedema in parts of the overlying cortical tissue as recently detected by in-vivo 
magnetic resonance imaging in rats (Sauer tal., 1992) which may interfere with 
the catalepsy response. 
Thus the degree of the anti-cataleptic effect is not only dependent on the 
dose of quinolinic acid as shown by Calderon et al. (1988), but is also critically 
dependent on the striatal area of the quinolinic acid lesion as shown by the 
present study. The latter finding is in accordance with the view of a functional 
heterogenity of the striatum. In the rat, the medial part of the CP receives 
prominent glutamatergic projections from the prefrontal cortex and this cortico- 
striatal loop has been implicated in processing cognitive functions. In contrast, 
the lateral striatum and the anatomically related sensorimotor cortical regions 
have been suggested tomediate motor functions (see Introduction). The present 
results further corroborate this concept since we found a functional differen- 
tiation of the medial and lateral CP with regard to catalepsy: the lateral CP as 
a part of the motor loop is a prerequisite for the expression of haloperidol 
induced catalepsy. Striatal infusion of haloperidol induced hindlimb rigidity in 
rats (Ellenbroek et al., 1988) as detected by a paw test (Ellenbroek et al., 1987). 
This effect could be mediated by haloperidols action within e lateral CP which 
includes limb representations i  rats (Ebrahimi et al., 1992). Thus a lesion in 
the lateral CP may counteract hindlimb rigidity and contribute to the antica- 
taleptic effect observed in the present study. 
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The concept of functional cortico-striato-cortical loops further implicates 
that lesions in different parts of the same loop should have similar behavioural 
consequences. This was in fact confirmed in different paradigms. For instance, 
lesions within the medial prefrontal cortex or the medial striatum produced 
similiar impairments in maze leafing (Dunnett and Iversen, 1981; Simon and 
LeMoal, 1984; Wikmark et al., 1973). The avaible catalepsy data further support 
a role of the motor loop for the expression of catalepsy: while extensive lesions 
of the frontal cortex reversed neuroleptic-induced catalepsy (Scatton et al., 1982; 
Warenycia etal., 1987; Worms etal., 1985; Yoshida etal., 1991), lesions of the 
medial prefrontal cortex induced only a weak anti-cataleptic effect (Carter and 
Pycock, 1987). 
Furthermore, the present results may have implications for the striatal site 
of action of systemically administered NMDA-antagonists: dizocilpine, apotent 
NMDA-antagonist reversed neuroleptic-induced catalepsy (Schmidt and Bub- 
ser, 1989; Metha and Ticku, 1990; Elliott etal., 1990b) and NMDA given 
systemically in combination with haloperidol potentiated the cataleptogenic 
effects of haloperidol (Metha and Ticku, 1990). From the present results one 
may conclude that within the CP the anti-cataleptic effects of systemically 
administered NMDA antagonists i mediated mainly through quinolinic acid- 
sensitive projection eurons in the lateral CP. 
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